Functional relationships between capacitation-dependent cell signaling and compartmentalized metabolic pathways in murine spermatozoa.
Spermatozoa are highly polarized cells with specific metabolic pathways compartmentalized in different regions. Previously, we hypothesized that glycolysis is organized in the fibrous sheath of the flagellum to provide ATP to dynein ATPases that generate motility and to protein kinases that regulate motility. Although a recent report suggested that glucose is not essential for murine sperm capacitation, we demonstrated that glucose (but not lactate or pyruvate) was necessary and sufficient to support the protein tyrosine phosphorylation events associated with capacitation. The effect of glucose on this signaling pathway was downstream of cAMP, and appeared to arise indirectly as a consequence of metabolism as opposed to a direct signaling effect. Moreover, the phosphorylation events were not affected by uncouplers of oxidative respiration, inhibitors of electron transfer, or by a lack of substrates for oxidative respiration in the medium. Further experiments aimed at identifying potential regulators of sperm glycolysis focused on a germ cell-specific isoform of hexokinase, HK1-SC, which localizes to the fibrous sheath. HK1-SC activity and biochemical localization did not change during sperm capacitation, suggesting that glycolysis in sperm is regulated either at the level of substrate availability or by downstream enzymes. These data support the hypothesis that ATP specifically produced by a compartmentalized glycolytic pathway in the principal piece of the flagellum, as opposed to ATP generated by mitochondria in the mid-piece, is strictly required for protein tyrosine phosphorylation events that take place during sperm capacitation. The relationship between these pathways suggests that spermatozoa offer a model system for the study of integration of compartmentalized metabolic and signaling pathways.
Travis
A J
AJ
Center for Research on Reproduction and Women's Health, Biomedical Research Building II/III, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-6142, USA.
Jorgez
C J
CJ
Merdiushev
T
T
Jones
B H
BH
Dess
D M
DM
Diaz-Cueto
L
L
Storey
B T
BT
Kopf
G S
GS
Moss
S B
SB
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis; D006593:Hexokinase / Q000737:chemistry; D015151:Immunoblotting; D007700:Kinetics; D019344:Lactic Acid / Q000494:pharmacology; D008297:Male; D051379:Mice; D010766:Phosphorylation / Q000187:drug effects; D020033:Protein Isoforms; D019289:Pyruvic Acid / Q000494:pharmacology; D015398:Signal Transduction; D013053:Spectrophotometry; D013075:Sperm Capacitation / Q000187:drug effects; D013094:Spermatozoa / Q000378:metabolism*; D013997:Time Factors; D014443:Tyrosine / Q000378:metabolism
D020033:Protein Isoforms; D019344:Lactic Acid; D014443:Tyrosine; D019289:Pyruvic Acid; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D006593:Hexokinase; D005947:Glucose